These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 22528487)
1. 1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics. Cuperlovic-Culf M; Ferguson D; Culf A; Morin P; Touaibia M J Biol Chem; 2012 Jun; 287(24):20164-75. PubMed ID: 22528487 [TBL] [Abstract][Full Text] [Related]
2. Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy. Shao W; Gu J; Huang C; Liu D; Huang H; Huang Z; Lin Z; Yang W; Liu K; Lin D; Ji T Mol Cancer; 2014 Aug; 13():197. PubMed ID: 25163530 [TBL] [Abstract][Full Text] [Related]
3. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics. St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249 [TBL] [Abstract][Full Text] [Related]
4. Metabolomic characterization of human glioblastomas and patient plasma: a pilot study. Liu YA; Aboud O; Dahabiyeh LA; Bloch O; Fiehn O F1000Res; 2024; 13():98. PubMed ID: 39371551 [TBL] [Abstract][Full Text] [Related]
5. Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome. Marziali G; Signore M; Buccarelli M; Grande S; Palma A; Biffoni M; Rosi A; D'Alessandris QG; Martini M; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Sci Rep; 2016 Feb; 6():21557. PubMed ID: 26857460 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788 [TBL] [Abstract][Full Text] [Related]
7. Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D (1) H INADEQUATE NMR. Martineau E; Tea I; Akoka S; Giraudeau P NMR Biomed; 2012 Aug; 25(8):985-92. PubMed ID: 22331830 [TBL] [Abstract][Full Text] [Related]
8. Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM. Mörén L; Perryman R; Crook T; Langer JK; Oneill K; Syed N; Antti H BMC Cancer; 2018 Feb; 18(1):167. PubMed ID: 29422017 [TBL] [Abstract][Full Text] [Related]
9. 1H NMR detects different metabolic profiles in glioblastoma stem-like cells. Guidoni L; Ricci-Vitiani L; Rosi A; Palma A; Grande S; Luciani AM; Pelacchi F; di Martino S; Colosimo C; Biffoni M; De Maria R; Pallini R; Viti V NMR Biomed; 2014 Feb; 27(2):129-45. PubMed ID: 24142746 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers. Kubelt C; Peters S; Ahmeti H; Huhndorf M; Huber L; Cohrs G; Hövener JB; Jansen O; Synowitz M; Held-Feindt J Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872409 [TBL] [Abstract][Full Text] [Related]
11. Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma. Kesarwani P; Prabhu A; Kant S; Chinnaiyan P Cancer Immunol Immunother; 2019 Jul; 68(7):1107-1120. PubMed ID: 31119318 [TBL] [Abstract][Full Text] [Related]
12. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237 [TBL] [Abstract][Full Text] [Related]
14. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
15. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
16. Identification of a panel of genes as a prognostic biomarker for glioblastoma. Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039 [TBL] [Abstract][Full Text] [Related]
17. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
18. Tumour xenograft detection through quantitative analysis of the metabolic profile of urine in mice. Moroz J; Turner J; Slupsky C; Fallone G; Syme A Phys Med Biol; 2011 Feb; 56(3):535-56. PubMed ID: 21212470 [TBL] [Abstract][Full Text] [Related]
19. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique. Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139 [TBL] [Abstract][Full Text] [Related]